One test to diagnose them all: Researchers exploit cancers' unique DNA signature

by Abu Sina, Laura G. Carrascosa And Matt Trau,The ConversationCredit: AI-generated imageResearchers have developed a test that could be used to diagnose all cancers. It is based on a unique DNA

Updated on: May 07,2024 20

One test to diagnose them all: Researchers exploit cancers' unique DNA signature

by Abu Sina, Laura G. Carrascosa And Matt Trau,The ConversationCredit: AI-generated imageResearchers have developed a test that could be used to diagnose all cancers. It is based on a unique DNA

Updated on:May 07,2024 20

Researchers predict 1.4 million deaths from all cancers in 2019 in the EU

by European Society for Medical OncologyCredit: CC0 Public DomainDeath rates from breast cancer are predicted to fall in all European Union (EU) countries in 2019 with the exception of Poland, ac

Updated on: March 09,2024 17

Researchers predict 1.4 million deaths from all cancers in 2019 in the EU

by European Society for Medical OncologyCredit: CC0 Public DomainDeath rates from breast cancer are predicted to fall in all European Union (EU) countries in 2019 with the exception of Poland, ac

Updated on:March 09,2024 17

Epigenetic drugs in the mission to beat rare cancers

by Simon Schmitt,Helmholtz Association of German Research CentresViability, SSTR2 protein levels, and [68Ga]Ga-DOTA-TATE uptake of MPC and MTT cells treated with epigenetic drugs; (A) Sequence o

Updated on: February 20,2024 17

Epigenetic drugs in the mission to beat rare cancers

by Simon Schmitt,Helmholtz Association of German Research CentresViability, SSTR2 protein levels, and [68Ga]Ga-DOTA-TATE uptake of MPC and MTT cells treated with epigenetic drugs; (A) Sequence o

Updated on:February 20,2024 17

'Hard to lose' mutations in tumors may predict response to immunotherapy

byJohns Hopkins University School of MedicineThe figure shows the interactions between immune cells (white) and tumor cells harboring persistent mutations (red) in the context of immunotherapy (

Updated on: January 22,2024 12

'Hard to lose' mutations in tumors may predict response to immunotherapy

byJohns Hopkins University School of MedicineThe figure shows the interactions between immune cells (white) and tumor cells harboring persistent mutations (red) in the context of immunotherapy (

Updated on:January 22,2024 12

New approach combines oncolytic virotherapy and adoptive T cell therapy for cancer treatment

by Bob Yirka , Medical XpressScheme of genome editing of PDL1 by eOA effectively improved virotherapy and adoptive T-cell therapy. Credit:Nature Biotechnology(2024). DOI: 10.1038/s41587-02

Updated on: March 05,2024 14

New approach combines oncolytic virotherapy and adoptive T cell therapy for cancer treatment

by Bob Yirka , Medical XpressScheme of genome editing of PDL1 by eOA effectively improved virotherapy and adoptive T-cell therapy. Credit:Nature Biotechnology(2024). DOI: 10.1038/s41587-02

Updated on:March 05,2024 14

Scientists create powerful, most-accurate tools to research deadliest blood cancer, study says

byThe Mount Sinai HospitalCredit: CC0 Public DomainTisch Cancer Center scientists have developed unique models of the deadliest blood cancer, acute myeloid leukemia (AML), creating a transformat

Updated on: January 22,2024 12

Scientists create powerful, most-accurate tools to research deadliest blood cancer, study says

byThe Mount Sinai HospitalCredit: CC0 Public DomainTisch Cancer Center scientists have developed unique models of the deadliest blood cancer, acute myeloid leukemia (AML), creating a transformat

Updated on:January 22,2024 12

'Never did I imagine that I would have to ration chemotherapy'

by Mary HynesCredit: CC0 Public DomainNationwide shortages of two dozen chemotherapy drugs are leading to rationing and delays in treatment for cancer patients, local and national authorities say.&quo

Updated on: January 10,2024 10

'Never did I imagine that I would have to ration chemotherapy'

by Mary HynesCredit: CC0 Public DomainNationwide shortages of two dozen chemotherapy drugs are leading to rationing and delays in treatment for cancer patients, local and national authorities say.&quo

Updated on:January 10,2024 10

Increasing the dose intensity of chemotherapy reduces the risk of breast cancer recurrence and death

by Medical Research CouncilCredit: PixabayGiving chemotherapy drugs every two weeks instead of the usual every three weeks reduces the risk of breast cancer recurrence and death, according to new

Updated on: March 08,2024 10

Increasing the dose intensity of chemotherapy reduces the risk of breast cancer recurrence and death

by Medical Research CouncilCredit: PixabayGiving chemotherapy drugs every two weeks instead of the usual every three weeks reduces the risk of breast cancer recurrence and death, according to new

Updated on:March 08,2024 10

Study finds younger kidney cancer survivors at significant risk for heart problems

byVirginia Commonwealth UniversityCredit: Pixabay/CC0 Public DomainNew research out of VCU Massey Cancer Center indicates that many adolescent and young adult kidney cancer survivors are at a si

Updated on: January 23,2024 18

Study finds younger kidney cancer survivors at significant risk for heart problems

byVirginia Commonwealth UniversityCredit: Pixabay/CC0 Public DomainNew research out of VCU Massey Cancer Center indicates that many adolescent and young adult kidney cancer survivors are at a si

Updated on:January 23,2024 18

Study: Cancer database's cases dropped 14% in pandemic's first year, indicating 200,000 'missing cases'

by Lisa Aubry, Loma Linda University Adventist Health Sciences CenterCredit:JAMA Surgery(2023). DOI: 10.1001/jamasurg.2023.0652Researchers say newly reported cases of cancer diagnoses decl

Updated on: January 16,2024 19

Study: Cancer database's cases dropped 14% in pandemic's first year, indicating 200,000 'missing cases'

by Lisa Aubry, Loma Linda University Adventist Health Sciences CenterCredit:JAMA Surgery(2023). DOI: 10.1001/jamasurg.2023.0652Researchers say newly reported cases of cancer diagnoses decl

Updated on:January 16,2024 19

Inflammation levels tied to severity of blood cancer

byNYU Langone HealthCredit: Unsplash/CC0 Public DomainSevere inflammation weakens the body's ability to kill cancerous blood cells in people with acute myeloid leukemia (AML), a new study sh

Updated on: January 16,2024 18

Inflammation levels tied to severity of blood cancer

byNYU Langone HealthCredit: Unsplash/CC0 Public DomainSevere inflammation weakens the body's ability to kill cancerous blood cells in people with acute myeloid leukemia (AML), a new study sh

Updated on:January 16,2024 18

Researchers describe a new method to test cancer drug toxicity

by Tufts UniversityCredit: Pixabay/CC0 Public DomainFor people with cancer, chemotherapy saves lives, but for some patients, the treatment comes with a side effect—heart damage. Screening cancer

Updated on: February 18,2024 11

Researchers describe a new method to test cancer drug toxicity

by Tufts UniversityCredit: Pixabay/CC0 Public DomainFor people with cancer, chemotherapy saves lives, but for some patients, the treatment comes with a side effect—heart damage. Screening cancer

Updated on:February 18,2024 11